| Literature DB >> 32946530 |
Yukiko Usui1, Ryo Kurokawa1, Eriko Maeda1, Harushi Mori1, Shiori Amemiya1, Jiro Sato1, Kenji Ino2, Rumiko Torigoe3, Osamu Abe1.
Abstract
This study aimed to evaluate the visualization of peripheral bronchioles in normal lungs via quarter-detector computed tomography (QDCT). Visualization of bronchioles within 10 mm from the pleura is considered a sign of bronchiectasis. However, it is not known peripheral bronchioles how close to the pleura in normal lungs can be tracked using QDCT. This study included 228 parts in 76 lungs from 38 consecutive patients who underwent QDCT. Reconstruction was performed with different thicknesses, increments, and matrix sizes: 0.5-mm thickness and increment with 512 and 1024 matrixes (Group5 and Group10, respectively) and 0.25-mm thickness and increment with 1024 matrix (Group10Thin). The distance between the most peripheral bronchiole visible and the pleura was determined in the three groups. The distance between the peripheral bronchial duct ends and the nearest pleural surface were significantly shorter in the order of Group10Thin, Group10, and Group5, and the mean distances from the pleura in Group10Thin and Group10 were shorter than 10 mm. These findings suggest the visualization of peripheral bronchioles in QDCT was better with a 1024 axial matrix than with a 512 matrix, and with a 0.25-mm slice thickness/increment than with a 0.5-mm slice thickness/increment. Our study also indicates bronchioles within 10 mm of the pleura do not necessarily indicate pathology.Entities:
Mesh:
Year: 2020 PMID: 32946530 PMCID: PMC7500691 DOI: 10.1371/journal.pone.0239459
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Images of lung fields are reconstructed with different thicknesses, increments, and matrix sizes, which are named as Group5 (a), Group10 (b), and Group10Thin (c). First, we chose a bronchiole randomly in Group5(a) (short arrow), and tracked the duct to the most peripherally visible end in Group5 (d) (black dot). Then, tracked the same bronchiole to its end in Group10(b) and Group10Thin(c) (short arrows). The distances between the bronchiole ends and the pleura in Group5(d), Group10(e), and Group10Thin(f) were measured (7.2 mm, 4.2 mm, and 4.0 mm, respectively in this case, long arrows). Image (d), (e), and (f) are the same slice images of image (a), (b), and (c), respectively, with annotations. Thick white lines and black dots show visible bronchiole ducts and their ends, respectively. Thin white lines show the distances between the ends and the pleura. The numbers below images mean matrix size and slice thickness / increment (mm).
Summary of patient characteristics.
| Age (year, mean ± standard deviation) | 65.6 ± 13.6 (36–86) |
| Sex (male/female) | 23/15 |
| The reason for CT (%) | |
| follow-up of lung nodules | 19/38 (50.0%) |
| screening or follow-up examination of lung metastasis | 9/38 (23.7%) |
| investigation of fever | 6/38 (15.8%) |
| follow-up examination after mediastinal surgery | 1/38 (2.6%) |
| investigation of a mediastinal mass | 1/38 (2.6%) |
| investigation of abnormal shadow in chest X-ray | 1/38 (2.6%) |
| screening for collagen disease | 1/38 (2.6%) |
Distances between peripheral bronchial ends and the nearest pleural surface in Group5, Group10, and Group10Thin.
| Group5 | Group10 | Group10Thin | |
|---|---|---|---|
| Distance between the bronchial ends and the pleura (mm, mean ± standard error) | 10.5 ± 0.07 | 8.9 ± 0.04 | 8.5 ± 0.05 |
| Number of bronchial ends found within 10mm of the pleura (%) | 98/228 (43.0%) | 152/228 (66.7%) | 160/228 (70.2%) |
*Group5 vs. Group10 vs. Group10Thin: p < 0.001 (Friedman test).
† Group5 vs. Group10: p < 0.001.
‡ Group5 vs. Group10Thin: p < 0.001.
§ Group10 vs. Group10Thin: p < 0.001.
†‡§ p values using Wilcoxon signed-rank test with Bonferroni correction (tripled original p values).
Radiation doses (mean ± standard error).
| total CTDIvol (mGy) | 10.9 ± 0.12 |
| total DLP (mGy.cm) | 465 ± 6.6 |
| Effective dose (mSv) | 6.5 ± 0.092 |
CTDIvol = Volume computed tomography dose index, DLP = dose length product.